01.08.2003
Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2003
Einloggen, um Zugang zu erhalten